Cell surface characteristics of human histiocytic lymphoma cell lines. II. Expression of Helix pomatia A hemagglutinin binding surface glycoproteins, HLA-DR and common acute lymphocytic leukemia (cALL) antigen. 1981

K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II

Related Publications

K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
January 1980, Leukemia research,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
February 1990, Acta pathologica japonica,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
June 1978, Journal of the National Cancer Institute,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
January 1983, Biochimica et biophysica acta,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
May 1983, Journal of immunology (Baltimore, Md. : 1950),
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
October 2007, The Korean journal of laboratory medicine,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
January 1980, Leukemia research,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
January 1995, Ultrastructural pathology,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
July 1993, Journal of clinical immunology,
K Nilsson, and A Kimura, and L Klareskog, and L C Anderson, and C G Gahmberg, and H Wigzell
October 1971, The Japanese journal of experimental medicine,
Copied contents to your clipboard!